Audopharma SRL
0.9 FTEAudopharma reported total assets of 483,083 € at the end of the 2025 financial year (annual accounts filed with the NBB on 07 Jul 2026), with 0.9 full-time equivalent.
The score of Audopharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets +14 % Headcount (avg FTE) +12 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Audopharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 43,610 € | ||||
| Equity | 233,319 € | ||||
| Cash | 131,988 € | ||||
| EBITDA | 61,275 € | ||||
| Total assets | 483,083 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Jul 2026
- Year ended 31 Dec 2024filed on 23 May 2025
- Year ended 31 Dec 2023filed on 05 Jun 2024
- Year ended 31 Dec 2022filed on 24 May 2023
- Year ended 31 Dec 2021filed on 17 Jun 2022
Audopharma's financial analysis
- Solvency48.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Audopharma
Audopharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0422.153.995
- VAT number
- BE0422153995
- Peppol
- Registered · 0208:0422153995 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Nov 1981
- Registered office
- 8660 De Panne
- Size
- Micro · 0.9 FTE
- Latest accounts
- 2025 · filed on 07 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Audopharma (SRL) has been based in De Panne since 1981, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 43,610 € and equity of 233,319 €; its revenue is not published. With 0.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 48.3%, above the median of its sector (44.2%).
Companies similar to Audopharma
Companies in the same business, of comparable size and area, outside its group.
- Internationale Apotheek Retail sale of pharmaceutical products Antwerp · balance sheet 483,003 €
- Pharma Lovenjoel Retail sale of pharmaceutical products Bierbeek · balance sheet 482,586 €
- Apotheek Godelaine Retail sale of pharmaceutical products Ostend · balance sheet 482,444 €
- Pharmacie Jacques Retail sale of pharmaceutical products Courcelles · balance sheet 485,161 €
- De Maeyer Groot-Bijgaarden Retail sale of pharmaceutical products Dilbeek · balance sheet 479,884 €
- City-Pharma Retail sale of pharmaceutical products Antwerp · balance sheet 478,952 €
- delta SUD PHARMA Retail sale of pharmaceutical products Virton · balance sheet 477,640 €
- Arendsapotheek Retail sale of pharmaceutical products Harelbeke · balance sheet 488,654 €
Frequently asked questions about Audopharma
What is the revenue of Audopharma?
Audopharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Audopharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0422153995 for Audopharma, if the company is VAT-registered. Its company number (CBE) is 0422.153.995.
Where is the registered office of Audopharma?
According to the CBE register, the registered office of Audopharma is in 8660 De Panne.
What is the equity of Audopharma?
At the close of the 2025 financial year, the equity of Audopharma amounts to 233,319 €, a solvency of 48.3% of total assets.
How many people work at Audopharma?
0.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Audopharma?
The register lists 2 active mandates at Audopharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Audopharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →